2003
DOI: 10.1097/00004424-200302000-00008
|View full text |Cite
|
Sign up to set email alerts
|

Percutaneous Radiofrequency Thermal Ablation of Lung VX2 Tumors in a Rabbit Model Using a Cooled Tip-Electrode

Abstract: This experimental study demonstrates the feasibility of RFA therapy for treating lung VX2 tumors in rabbits, although RFA for central tumors carries the potential for major complications, including large pneumothorax or obstructive pneumonia.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
2

Citation Types

0
7
0

Year Published

2004
2004
2019
2019

Publication Types

Select...
8
1

Relationship

0
9

Authors

Journals

citations
Cited by 34 publications
(7 citation statements)
references
References 32 publications
0
7
0
Order By: Relevance
“…As the electrode is placed percutaneously directly into the tumor under cross-sectional imaging guidance, such as chest CT, complications such as pneumothorax occur at relatively high rates. The frequency of pneumothorax or hemothorax with use of percutaneous direct electrode placement was 47% in a rabbit model [9]. Clinical complications occurring in percutaneously directly RFA were 16%–35% [3, 4].…”
Section: Discussionmentioning
confidence: 99%
“…As the electrode is placed percutaneously directly into the tumor under cross-sectional imaging guidance, such as chest CT, complications such as pneumothorax occur at relatively high rates. The frequency of pneumothorax or hemothorax with use of percutaneous direct electrode placement was 47% in a rabbit model [9]. Clinical complications occurring in percutaneously directly RFA were 16%–35% [3, 4].…”
Section: Discussionmentioning
confidence: 99%
“…Studies performing CT-guided (rather than real-time CT fluoroscopy-guided) VX2 tumor cell inoculations with or without Matrigel and with 18- or 21-gauge needles have reported successful formation rates of VX2 lung cancer of 45.8–77.8%; however, multiple rather than solitary lesions were obtained [25–27]. Similar to the procedures performed in previous studies, we first percutaneously injected VX2 tissue suspensions without Matrigel using an 18-gauge needle under real-time CT fluoroscopy guidance (group 1).…”
Section: Discussionmentioning
confidence: 99%
“…Previous studies of lung cancer have reported CT-guided inoculations of VX2 tumor cell suspensions [25–27]. However, the success rate of such inoculations in lung cancer models of solitary tumors was low because injection of the suspension into the lung parenchyma was difficult to confirm in real time.…”
Section: Introductionmentioning
confidence: 99%
“…This is further complicated by heterogeneity in the time from inoculation to sacrifice (ranging from days to months). It is known that VX2 lung tumor models can generate nodal metastases, but this has been largely demonstrated on autopsy after animals died from uncontrolled disease at 26 to around 40 days [12, 13]. Those studies that stratified rabbits by time from inoculation did so for assessing changes on imaging or responses to radiofrequency ablation; the timing of nodal metastasis development was therefore unclear [12, 14].…”
Section: Introductionmentioning
confidence: 99%